← FDA DRUG APPROVALS

FDA ANDA · ANDA077641

ZONISAMIDE

Sponsor: ANI PHARMS

APPLICATION
ANDA077641
TYPE
ANDA
ORIGINAL APPROVAL
2005-12-22
LATEST ACTION
2019-10-25
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

ZONISAMIDEDiscontinued
ZONISAMIDE 25MG · CAPSULE · ORAL
ZONISAMIDEDiscontinued
ZONISAMIDE 100MG · CAPSULE · ORAL
ZONISAMIDEDiscontinued
ZONISAMIDE 50MG · CAPSULE · ORAL

Approval history

2019-10-25Labeling · Supplement 4 · standardAP
2007-12-12Labeling · Supplement 3AP
2007-06-14Labeling · Supplement 2AP
2006-12-21Labeling · Supplement 1AP
2005-12-22OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →